Alternating Lenvatinib and Trans-Arterial Therapy Prolongs Overall Survival in Patients with Inter-Mediate Stage HepatoCellular Carcinoma: A Propensity Score Matching Study

SIMPLE SUMMARY: This study aimed to investigate the efficacy of alternating lenvatinib (LEN) and trans-arterial therapy (AT) in patients with intermediate-stage hepatocellular carcinoma (HCC) after propensity score matching analysis. AT and albumin-bilirubin (ALBI) grade 1 were identified as indepen...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimose, Shigeo, Iwamoto, Hideki, Tanaka, Masatoshi, Niizeki, Takashi, Shirono, Tomotake, Noda, Yu, Kamachi, Naoki, Okamura, Shusuke, Nakano, Masahito, Suga, Hideya, Yamaguchi, Taizo, Kawaguchi, Takumi, Kuromatsu, Ryoko, Noguchi, Kazunori, Koga, Hironori, Torimura, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796435/
https://www.ncbi.nlm.nih.gov/pubmed/33466496
http://dx.doi.org/10.3390/cancers13010160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796435/
https://www.ncbi.nlm.nih.gov/pubmed/33466496
http://dx.doi.org/10.3390/cancers13010160

Ejemplares similares